Toll Free: 1-888-928-9744

Tonix Pharmaceuticals Holding Corp. - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Tonix Pharmaceuticals Holding Corp. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Tonix Pharmaceuticals Holding Corp. - Product Pipeline Review - 2014', provides an overview of the Tonix Pharmaceuticals Holding Corp.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tonix Pharmaceuticals Holding Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Tonix Pharmaceuticals Holding Corp. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Tonix Pharmaceuticals Holding Corp.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Tonix Pharmaceuticals Holding Corp.'s pipeline products

Reasons to buy

- Evaluate Tonix Pharmaceuticals Holding Corp.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Tonix Pharmaceuticals Holding Corp. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Tonix Pharmaceuticals Holding Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Tonix Pharmaceuticals Holding Corp. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tonix Pharmaceuticals Holding Corp.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Tonix Pharmaceuticals Holding Corp. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Tonix Pharmaceuticals Holding Corp. Snapshot 5
Tonix Pharmaceuticals Holding Corp. Overview 5
Key Information 5
Key Facts 5
Tonix Pharmaceuticals Holding Corp. - Research and Development Overview 6
Key Therapeutic Areas 6
Tonix Pharmaceuticals Holding Corp. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Tonix Pharmaceuticals Holding Corp. - Pipeline Products Glance 11
Tonix Pharmaceuticals Holding Corp. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Tonix Pharmaceuticals Holding Corp. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Tonix Pharmaceuticals Holding Corp. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Tonix Pharmaceuticals Holding Corp. - Drug Profiles 15
TNX-102 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
TNX-201 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
(disulfiram + selegiline) 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecules for Radiation and Chemical Toxicity 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
small pox vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Tonix Pharmaceuticals Holding Corp. - Pipeline Analysis 21
Tonix Pharmaceuticals Holding Corp. - Pipeline Products by Target 21
Tonix Pharmaceuticals Holding Corp. - Pipeline Products by Route of Administration 22
Tonix Pharmaceuticals Holding Corp. - Pipeline Products by Molecule Type 23
Tonix Pharmaceuticals Holding Corp. - Pipeline Products by Mechanism of Action 24
Tonix Pharmaceuticals Holding Corp. - Recent Pipeline Updates 25
Tonix Pharmaceuticals Holding Corp. - Dormant Projects 29
Tonix Pharmaceuticals Holding Corp. - Locations And Subsidiaries 30
Head Office 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32
List of Tables
Tonix Pharmaceuticals Holding Corp., Key Information 5
Tonix Pharmaceuticals Holding Corp., Key Facts 5
Tonix Pharmaceuticals Holding Corp. - Pipeline by Indication, 2014 7
Tonix Pharmaceuticals Holding Corp. - Pipeline by Stage of Development, 2014 8
Tonix Pharmaceuticals Holding Corp. - Monotherapy Products in Pipeline, 2014 9
Tonix Pharmaceuticals Holding Corp. - Combination Treatment Modalities in Pipeline, 2014 10
Tonix Pharmaceuticals Holding Corp. - Phase III, 2014 11
Tonix Pharmaceuticals Holding Corp. - Phase II, 2014 12
Tonix Pharmaceuticals Holding Corp. - Phase I, 2014 13
Tonix Pharmaceuticals Holding Corp. - Preclinical, 2014 14
Tonix Pharmaceuticals Holding Corp. - Pipeline Products by Target, 2014 21
Tonix Pharmaceuticals Holding Corp. - Pipeline by Route of Administration, 2014 22
Tonix Pharmaceuticals Holding Corp. - Pipeline by Molecule Type, 2014 23
Tonix Pharmaceuticals Holding Corp. - Pipeline Products by Mechanism of Action, 2014 24
Tonix Pharmaceuticals Holding Corp. - Recent Pipeline Updates, 2014 25
Tonix Pharmaceuticals Holding Corp. - Dormant Developmental Projects,2014 29 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify